ProQR Therapeutics N.V. - SHS EURO (PRQR)

Historical Portfolio Holders from Q3 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / SHS EURO
Shares, excl. options Q1 2024
17.3 M
Holdings value Q1 2024
$39.5 M
Value change Q1 2024
-$2.23 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
45
Number of buys Q1 2024
13
Number of sells Q1 2024
-15
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
N71542109
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 17.3 M $39.5 M -$2.23 M $2.29 45
2023 Q4 18.3 M $36.7 M -$1.05 K $1.98 43
2023 Q3 18.2 M $23.7 M -$3.6 M $1.30 42
2023 Q2 21.1 M $34.2 M -$2.17 M $1.62 49
2023 Q1 22.3 M $47.5 M +$11.1 M $2.13 52
2022 Q4 16.7 M $59.9 M -$4.78 M $3.70 43
2022 Q3 20.1 M $15 M -$757 K $0.74 39
2022 Q2 21.7 M $16.9 M -$8.62 M $0.78 44
2022 Q1 31.5 M $28.6 M -$92 M $0.91 57
2021 Q4 45.4 M $364 M +$6.65 M $8.01 68
2021 Q3 39.6 M $331 M +$12.2 M $8.37 64
2021 Q2 38.2 M $258 M -$31.8 M $6.74 60
2021 Q1 43 M $284 M +$121 M $6.61 61
2020 Q4 24.9 M $105 M -$8.2 M $4.20 43
2020 Q3 27.7 M $133 M -$5.87 M $4.79 38
2020 Q2 28.8 M $175 M -$842 K $6.08 41
2020 Q1 29 M $159 M -$7.2 M $5.49 40
2019 Q4 30 M $298 M +$87.2 M $9.91 50
2019 Q3 21.7 M $125 M -$19.2 M $5.76 46
2019 Q2 23.6 M $215 M -$8.5 M $9.10 51
2019 Q1 23.9 M $332 M +$9.45 M $13.87 52
2018 Q4 23.1 M $364 M +$53.1 M $15.78 56
2018 Q3 19.5 M $376 M +$166 M $19.35 35
2018 Q2 11.1 M $80.8 M +$5.44 M $7.30 24
2018 Q1 10.7 M $32.9 M -$2.76 M $3.08 23
2017 Q4 11.5 M $37.1 M +$4.39 M $3.22 25
2017 Q3 10.1 M $48.9 M +$5.21 M $4.85 22
2017 Q2 9 M $46.8 M +$1.97 M $5.20 17
2017 Q1 9.01 M $45 M +$634 K $5.00 19
2016 Q4 8.89 M $43.6 M +$398 K $4.90 21
2016 Q3 8.69 M $58 M -$2.94 M $6.67 25
2016 Q2 9.14 M $44.2 M -$2.33 M $4.84 25
2016 Q1 9.57 M $46.7 M -$10.7 M $4.88 27
2015 Q4 11.2 M $97.1 M -$3.47 M $8.68 32
2015 Q3 11.1 M $162 M +$4.01 M $14.57 35
2015 Q2 10.8 M $181 M -$5.7 M $16.67 35
2015 Q1 11 M $241 M +$65.7 M $21.88 37
2014 Q4 8.02 M $173 M +$8.84 M $21.67 35
2014 Q3 7.63 M $130 M +$130 M $17.19 30